Corrigendum to “The SIRT6 allosteric activator MDL-800 suppresses calcium oxalate nephrocalcinosis by alleviating inflammatory and renal damage” [Int. Immunopharmacol. 146 (2025) 113864]

Lvwen Zhang, Zhenyu Song, Xike Mao, Yuehan Yang, Bingbing Hou, Yang Chen, Zongyao Hao
International Immunopharmacology · Elsevier · DOI: 10.1016/j.intimp.2026.117587

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles